Covaxin | The Asian Age

Friday, Apr 26, 2024 | Last Update : 08:35 AM IST

Covaxin Page-2

A health worker carries vials of the Covaxin vaccine against the Covid-19 coronavirus at a health centre in New Dehi. (Photo: AFP/File)

Expert Committee recommends Covaxin for children, DCGI nod awaited

The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September

12 Oct 2021 1:42 PM

Bharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine. (PTI)

WHO to decide on Bharat Biotech's Covaxin emergency usage in October

The duration of the emergency use listing process depends on the quality of the data which is submitted by the vaccine manufacturer

30 Sep 2021 1:22 PM

WHO's emergency use authorisation for Covaxin further delayed: Sources

The Strategic Advisory Group of Expert on Immunization (SAGE) will be meeting on October 5 on EUA to Covaxin

28 Sep 2021 2:07 PM

Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18 years

On the production levels of Covaxin, Ella said 100 million doses per month can be possible

21 Sep 2021 2:24 PM

A health worker prepares a dose of Covaxin vaccine against Covid-19 coronavirus at a vaccination centre in New Delhi. (Photo: AFP/File)

WHO Experts' Group to take a call on EUL for Covaxin on October 6

Bharat Biotech is expected to give a presentation on the Vaccine's safety and efficacy data of clinical trials

19 Sep 2021 10:55 AM

Suchitra Ella, joint managing director of Bharat Biotech recently had earlier said the EUL process is a step closer to the final decision on Covaxin's 'global acceptance.' (Photo: AFP)

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process

17 Sep 2021 2:31 PM

People get inoculated with the dose of the Covaxin Covid-19 coronavirus vaccine at a temporary vaccination camp inside a school in Mumbai. (Indranil MUKHERJEE / AFP)

'Number of people who got at least one dose of COVID jab in India highest in world'

Presently, about 60.7 per cent of the adult population in the country has received at least one dose of COVID-19 vaccine, the ministry said

15 Sep 2021 10:48 AM

The solution must be easy to use and low-resource, like Logmore, which uses QR codes that are trackable through any smartphone. — By arrangement

How tech can help India reach vaccine goals and slow down its COVID-19 disaster

India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain

30 Aug 2021 9:57 PM

A health worker administers the vaccine for COVID-19 at District Govt Women's Hospital in Varanasi. (Photo: AP)

India logs 45,083 new COVID-19 cases

The death toll has climbed to 4,37,830 with 460 fresh fatalities

29 Aug 2021 10:17 AM

The report also quoted other studies that have reported a reduction in neutralisation among Covishield and Covaxin vaccine beneficiaries after infection with the Delta variant. (Representational image: AP)

ICMR study in Chennai shows vaccination reduces mortality due to Delta variant

The prevalence of the Delta variant or B.1.617.2 was not different between the vaccinated and un-vaccinated groups

19 Aug 2021 1:00 PM

The mixing and matching of Covid-19 vaccines may possibly do more good than harm, a study conducted by the Indian Council of Medical Research has claimed. (Representational Photo:AP)

ICMR: Cocktail of Covaxin, Covishield is ‘safe, better’

The study was done by ICMR on 18 individuals who were inadvertently given a shot of Covaxin after their first dose of the Covishield in UP

09 Aug 2021 12:41 AM

Johnson & Johnson will further boost the country's collective fight against the novel coronavirus infection. (Reuters/File Photo)

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India

The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson

07 Aug 2021 2:37 PM

Bharat Biotech terminated the MoU it entered with Precisa Medicamentos and Envixia Pharmaceuticals LLC for its COVID-19 vaccine Covaxin for Brazilian market. (Representational image: AFP)

After suspending EUA request, Brazil now shelves import authorisation of Covaxin

Bharat Biotech will continue to work diligently with Anvisa, to complete the regulatory approval process for Covaxin

29 Jul 2021 12:13 PM

Bharat Biotech on July 23 said it terminated the MoU it entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for Brazilian market. (Representational image: AFP)

Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact

Termination of the MoU came after the deal with the Brazilian Government for supply of 20 million doses of Covaxin landed in controversy

27 Jul 2021 10:28 AM

A health worker carries vials of the Covaxin vaccine against the Covid-19 coronavirus at a health centre in New Dehi. (Photo: AFP)

Second dose trial of Covaxin on 2-6 years to begin by next week

According to sources, children in the above-mentioned age group have already received the first dose of the vaccine

23 Jul 2021 9:52 AM

WHO assessing Covaxin data for EUL; Decision date 'to be confirmed'

Rolling data allows the WHO to start its review right away to accelerate the overall review process

20 Jul 2021 10:49 AM

Domestic vaccine manufacturers are given the option to provide 25 per cent of their monthly production of vaccines to private hospitals. (Representational Photo: AFP)

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes

17 Jul 2021 12:53 PM

People sit in the observation area after being inoculated with a dose of the Covaxin vaccine against the Covid-19 coronavirus at a vaccination centre in Manipal Hospital in Bangalore on June 18, 2021. (Manjunath Kiran / AFP)

Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech

The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19

13 Jul 2021 8:36 AM

At present, the WHO has approved vaccines by Pfizer/BioNTech, Astrazeneca-SK Bio/Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm for emergency use. (PTI Photo)

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

Swaminathan said WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal

10 Jul 2021 5:01 PM

Phase 3 clinical trials of the vaccine was an event driven analysis of 130 symptomatic COVID-19 cases, reported at least two weeks after the second dose, conducted at 25 sites across India. (PTI)

Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases

03 Jul 2021 10:50 AM

2 of 5

Columns

Sunil Gatade